Insights

The finalized Form 6765 instructions mark the IRS's shift to a project-specific disclosure approach. Explore what the new rules mean for R&D tax credits.

Discover how SB 711 reshapes California R&D tax credits for 2026 with ASC adoption, immediate expensing and planning opportunities for businesses.

Uncover the key takeaways from IRS Notice 2026-11, which provides interim guidance on additional first-year deduction depreciation under Section 168(k).

Manufacturers can leverage state tax credits to reduce costs. Learn about key tax subsidies an how they can support business growth.

Prepare for Georgia's tax credit changes including HB 1181, reduced tax credit durations, sunset dates and planning tips for businesses and individuals.

Learn how R&D capitalization works, its benefits and about the proposed changes that could affect the existing process under Section 174.

The clinical stage of drug development involves navigating the phases of clinical trials and fundraising to support them. Explore our guide for startups.

Starting in the 2025 tax year, the Section 174 repeal lets businesses immediately deduct domestic R&E expenditures. Explore what else is changing.

Explore the implications of Virginia’s R&D tax credit sunset on strategic tax planning and gain insights into the 2026 outlook for its potential revival.

Explore our guide to navigating the growth stage for tech startups. Understand the key elements, considerations and solutions to common challenges.